Interaction of At1-Receptor Antagonists and Thiazolidindiones with the Atp-Binding Cassette Transporters P-Gp, Bcrp, Mrp1, and Mrp2

被引:0
|
作者
Sauer, Alexandra [1 ]
Benndorf, Ralf [2 ]
Boeger, Rainer [2 ]
Haefeli, Walter Emil [1 ]
Weiss, Johanna [1 ]
机构
[1] Univ Klinikum Heidelberg Innere Med VI, Klin Pharmakol & Pharmakoepidemiol, D-69120 Heidelberg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Expt & Klin Pharmakol & Toxikol, D-20246 Hamburg, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:519 / 519
页数:1
相关论文
共 50 条
  • [31] The interaction of curcumin and its glutathione conjugate with the multidrug resistance proteins MRP1 and MRP2
    Wortelboer, HM
    Usta, M
    van der Velde, AE
    van Zanden, JJ
    Rietjens, IMCM
    van Bladeren, PJ
    Cnubben, NHP
    DRUG METABOLISM REVIEWS, 2002, 34 : 92 - 92
  • [32] Investigation of the transport of valproic acid by the multidrug transporters P-gp (ABCB1) and MRP2 (ABCC2)
    Baltes, S
    Potschka, H
    Löscher, W
    EPILEPSIA, 2005, 46 : 205 - 206
  • [33] Expression of multidrug transporters MRP1 and MRP2 during epileptogenesis in a rat model for temporal lobe epilepsy
    van Vliet, EA
    Aronica, E
    Gorter, JA
    EPILEPSIA, 2004, 45 : 205 - 206
  • [34] ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
    Daood, M.
    Tsai, C.
    Ahdab-Barmada, M.
    Watchko, J. F.
    NEUROPEDIATRICS, 2008, 39 (04) : 211 - 218
  • [35] Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure
    Laouari, D
    Yang, RC
    Veau, C
    Blanke, I
    Friedlander, G
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (04) : F636 - F645
  • [36] In Vitro Evaluation Of P-gp, BCRP And MRP2 In Caco-2 Cells Using Probe Substrates And Inhibitors
    Newbury, Gayle
    Ellis, Samantha
    Mistry, Divya
    Turner, David
    James, Andrew
    Clarkson, Andy
    Dilworth, Clive
    DRUG METABOLISM REVIEWS, 2010, 42 : 318 - 319
  • [37] Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Using Loperamide, Paclitaxel, Sulfasalazine, and Carboxydichlorofluorescein Pharmacokinetics
    Zamek-Gliszczynski, Maciej J.
    Bedwell, David W.
    Bao, Jing Q.
    Higgins, J. William
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1825 - 1833
  • [38] Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
    Chen, Yu-Lun
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Wu, Chieh-Liang
    Hsu, Shih-Lan
    Hsueh, Chi-Mei
    CELLULAR ONCOLOGY, 2016, 39 (05) : 411 - 433
  • [39] Reduced expression of the ATP-binding cassette transporter superfamily gene MRP2 in human hepatocellular carcinoma.
    Taguchi, KI
    Hinoshita, E
    Shimada, M
    Sugimachi, K
    Kuwano, M
    Tsuneyoshi, M
    HEPATOLOGY, 2001, 34 (04) : 677A - 677A
  • [40] Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
    Yu-Lun Chen
    Tsung-Ying Yang
    Kun-Chieh Chen
    Chieh-Liang Wu
    Shih-Lan Hsu
    Chi-Mei Hsueh
    Cellular Oncology, 2016, 39 : 411 - 433